Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Genor Biopharma Holdings Limited ( (HK:6998) ) has provided an announcement.
Genor Biopharma Holdings Limited has announced the composition of its board of directors, including executive, non-executive, and independent non-executive directors. The board has established three committees: audit, compensation, and nomination, with specific directors assigned to each, which reflects the company’s commitment to strong corporate governance and strategic oversight.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company is involved in the development and commercialization of innovative biologic therapies, focusing on oncology and autoimmune diseases.
Average Trading Volume: 1,001,468
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.34B
See more insights into 6998 stock on TipRanks’ Stock Analysis page.